Loomis Sayles & Co. L P Boosts Holdings in Privia Health Group, Inc. (NASDAQ:PRVA)

Loomis Sayles & Co. L P grew its position in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 55.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,418,234 shares of the company's stock after purchasing an additional 503,002 shares during the quarter. Loomis Sayles & Co. L P owned approximately 1.18% of Privia Health Group worth $27,727,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also bought and sold shares of the stock. Park Avenue Securities LLC boosted its position in Privia Health Group by 3.8% in the 4th quarter. Park Avenue Securities LLC now owns 14,697 shares of the company's stock valued at $287,000 after buying an additional 532 shares during the period. PNC Financial Services Group Inc. boosted its stake in shares of Privia Health Group by 8.0% in the fourth quarter. PNC Financial Services Group Inc. now owns 7,169 shares of the company's stock worth $140,000 after buying an additional 533 shares during the last quarter. First Horizon Advisors Inc. grew its position in Privia Health Group by 53.8% during the fourth quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company's stock valued at $35,000 after buying an additional 632 shares during the period. WINTON GROUP Ltd raised its stake in shares of Privia Health Group by 1.5% during the 4th quarter. WINTON GROUP Ltd now owns 60,607 shares of the company's stock worth $1,185,000 after buying an additional 902 shares during the period. Finally, HighTower Advisors LLC increased its stake in Privia Health Group by 5.0% during the 4th quarter. HighTower Advisors LLC now owns 19,469 shares of the company's stock worth $381,000 after buying an additional 932 shares in the last quarter. Hedge funds and other institutional investors own 94.48% of the company's stock.

Remove Ads

Analyst Ratings Changes

Several brokerages have recently commented on PRVA. Macquarie assumed coverage on shares of Privia Health Group in a report on Monday, December 16th. They issued an "outperform" rating and a $25.00 price objective on the stock. Stephens reissued an "overweight" rating and set a $26.00 price target on shares of Privia Health Group in a report on Thursday, January 2nd. Needham & Company LLC restated a "buy" rating and set a $30.00 target price on shares of Privia Health Group in a research report on Friday, March 21st. JMP Securities set a $29.00 price objective on shares of Privia Health Group in a research note on Friday, February 28th. Finally, Canaccord Genuity Group boosted their price objective on shares of Privia Health Group from $29.00 to $30.00 and gave the stock a "buy" rating in a report on Friday, February 28th. One investment analyst has rated the stock with a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Privia Health Group has an average rating of "Buy" and a consensus target price of $26.67.

Privia Health Group Stock Up 2.4 %

PRVA traded up $0.54 during mid-day trading on Tuesday, reaching $22.99. 261,104 shares of the company traded hands, compared to its average volume of 772,073. Privia Health Group, Inc. has a 52-week low of $15.92 and a 52-week high of $26.04. The stock has a market capitalization of $2.77 billion, a P/E ratio of 230.12, a P/E/G ratio of 3.47 and a beta of 0.85. The company's fifty day moving average price is $23.80 and its 200-day moving average price is $21.23.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.